Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
3.510
-0.050 (-1.40%)
At close: Apr 28, 2026, 4:00 PM EDT
3.530
+0.020 (0.57%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Adagene Market Cap
Adagene has a market cap or net worth of $231.91 million as of April 28, 2026. Its market cap has increased by 232.63% in one year.
Market Cap
231.91M
Enterprise Value
169.60M
1-Year Change
232.63%
Ranking
Category
Stock Price
$3.51
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $231.91M, a decrease of -71.16%. That is a compound annual growth rate of -21.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 235.22M | 164.06% |
| Dec 31, 2025 | 89.08M | 1.11% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Artiva Biotherapeutics | 255.08M |
| SAB Biotherapeutics | 247.37M |
| Sol-Gel Technologies | 244.62M |
| Arcturus Therapeutics Holdings | 244.15M |
| Orchestra BioMed Holdings | 241.69M |
| Codexis | 238.08M |
| Fennec Pharmaceuticals | 235.81M |
| Nuvectis Pharma | 235.78M |